Hywel Griffiths
Chief Tech/Sci/R&D Officer bij FERMENTALG
Profiel
Hywel Griffiths is currently the Chief Scientific Officer at Fermentalg SA since 2014.
Prior to this, he held the same position at Photonz Corp.
Ltd.
Dr. Griffiths received his undergraduate and doctorate degrees from the University of Cambridge.
Actieve functies van Hywel Griffiths
| Bedrijven | Functie | Begin |
|---|---|---|
| FERMENTALG | Chief Tech/Sci/R&D Officer | 02-09-2014 |
Eerdere bekende functies van Hywel Griffiths
| Bedrijven | Functie | Einde |
|---|---|---|
Photonz Corp. Ltd.
 Photonz Corp. Ltd. BiotechnologyHealth Technology Photonz Corp. Ltd. operates as a biotechnology company which produces the omega-3 fatty acid eicosapentaenoic acid. Its products include PNZC0901, a fermentation drug substance comprising high purity eicosapentaenoic acid. The company was founded by Karl Thomas Geiringer on April 17, 2015 and is headquartered in Auckland, New Zealand. | Chief Tech/Sci/R&D Officer | - |
Opleiding van Hywel Griffiths
| University of Cambridge | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| FERMENTALG | Consumer Non-Durables |
| Bedrijven in privébezit | 1 |
|---|---|
Photonz Corp. Ltd.
Photonz Corp. Ltd. BiotechnologyHealth Technology Photonz Corp. Ltd. operates as a biotechnology company which produces the omega-3 fatty acid eicosapentaenoic acid. Its products include PNZC0901, a fermentation drug substance comprising high purity eicosapentaenoic acid. The company was founded by Karl Thomas Geiringer on April 17, 2015 and is headquartered in Auckland, New Zealand. | Health Technology |
